A study using AI radiographic analysis linked unfractionated heparin exposure in pregnancy to reduced maternal bone density, positioning routine chest X-ray data as an input for detecting skeletal risk signals. The reporting frames the work as a “hidden threat” hypothesis that could influence how clinicians track adverse effects in pregnant patients receiving heparin. The approach also signals a broader trend: models trained on imaging can surface associations that are hard to observe through conventional chart review alone. While the report does not specify causality, it emphasizes a potentially actionable safety signal tied to a widely used anticoagulant class. For biotech and medtech teams building imaging analytics, the study illustrates the pressure to move from retrospective associations to prospective validation and clinically interpretable risk stratification.